StockWatch
·
Pharmaceuticals
Board Meeting20 May 2026, 09:01 pm

Parnax Lab Board Meeting on May 28, 2026

AI Summary

Parnax Lab Ltd has scheduled a Board of Directors meeting on May 28, 2026, to consider and approve the Standalone and Consolidated Audited IND-AS Compliant Financial Results along with the Auditor's Report for the quarter (Q4) and year ended March 31, 2026. The trading window has been closed from April 1, 2026, and will open 48 hours after the declaration of the audited financial results.

Key Highlights

  • Board meeting scheduled for May 28, 2026, to approve audited financial results.
  • Standalone and Consolidated Audited IND-AS Compliant Financial Results to be considered.
  • Trading window closed from April 1, 2026, reopening 48 hours post-results.
  • Meeting to also address any other business with the Chair's permission.